Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriho Iida

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Gastroenterology|February 12, 2017
Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular CarcinomaHidetoshi Nakagawa, Eishiro Mizukoshi, Eiji Kobayashi, et al.
Hepatology (Baltimore, Md.)|April 3, 2019
Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus InfectionAtsushi Yonejima, Eishiro Mizukoshi, Toshikatsu Tamai, et al.
Journal of Gastroenterology|March 4, 2020
Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patientsTakuya Seike, Eishiro Mizukoshi, Kazutoshi Yamada, et al.
Genome Biology|November 27, 2019
Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse hostJun Seishima, Noriho Iida, Kazuya Kitamura, et al.
Scientific Reports|March 6, 2020
A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinomaToshikatsu Tamai, Eishiro Mizukoshi, Masashi Kumagai, et al.
Digestion|February 20, 2022
Oral Corticosteroids Impair Mucin Production and Alter the Posttransplantation Microbiota in the GutHirofumi Okafuji, Noriho Iida, Kazuya Kitamura, et al.
Cancers|January 25, 2025
Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with LenvatinibTakeshi Terashima, Hidenori Kido, Noboru Takata, et al.
Diabetes Care|July 27, 2022
Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled TrialYumie Takeshita, Masao Honda, Kenichi Harada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinomaTakeshi Terashima, Makoto Yamamoto, Tadashi Toyama, et al.
Life (Basel, Switzerland)|September 9, 2020
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with CirrhosisTsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Gastroenterology|February 12, 2017
Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular CarcinomaHidetoshi Nakagawa, Eishiro Mizukoshi, Eiji Kobayashi, et al.
Hepatology (Baltimore, Md.)|April 3, 2019
Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus InfectionAtsushi Yonejima, Eishiro Mizukoshi, Toshikatsu Tamai, et al.
Journal of Gastroenterology|March 4, 2020
Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patientsTakuya Seike, Eishiro Mizukoshi, Kazutoshi Yamada, et al.
Genome Biology|November 27, 2019
Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse hostJun Seishima, Noriho Iida, Kazuya Kitamura, et al.
Scientific Reports|March 6, 2020
A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinomaToshikatsu Tamai, Eishiro Mizukoshi, Masashi Kumagai, et al.
Digestion|February 20, 2022
Oral Corticosteroids Impair Mucin Production and Alter the Posttransplantation Microbiota in the GutHirofumi Okafuji, Noriho Iida, Kazuya Kitamura, et al.
Cancers|January 25, 2025
Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with LenvatinibTakeshi Terashima, Hidenori Kido, Noboru Takata, et al.
Diabetes Care|July 27, 2022
Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled TrialYumie Takeshita, Masao Honda, Kenichi Harada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinomaTakeshi Terashima, Makoto Yamamoto, Tadashi Toyama, et al.
Life (Basel, Switzerland)|September 9, 2020
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with CirrhosisTsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, et al.
Pageof 6